Senores Pharmaceuticals Ltd reports Q2 FY27 revenue of ₹192.3 crore, up 24.9% YoY, and net profit of ₹37 crore, up 22%
- Q2 EBITDA rose 38% to ₹58 crore; EBITDA margin expanded approximately 290 bps YoY to 30.2%.
- H1 FY27 revenue increased 30% to ₹372.5 crore; EBITDA rose 58% to ₹111 crore and net profit grew 31% to ₹67 crore.